Fennec Pharmaceuticals (FRX.TO) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.3
-0.01
0.27
0.56

Details

Expected EPS
-0.1261170327906
Actual EPS
-0.29836708004879997
Surprise EPS
-0.17
Surprise Percent
+136.58%

Description

Fennec Pharmaceuticals (FRX.TO) has reported earnings of -0.29836708004879997 per share for Q4 2024.

0 Comments

Share your thoughts